Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity

by Karen M. Henkels, Kristen M. Rehl, Kwang-jin Cho
Published 2021-06-01

Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding

by Michael J. McCarthy, Cynthia V. Pagba, Priyanka Prakash, Ali K. Naji, Dharini van der Hoeven, Hong Liang, Amit K. Gupta, Yong Zhou, Kwang-Jin Cho, John F. Hancock, Alemayehu A. Gorfe
Published 2019-02-01